Latest Articles

Publication Date
Milestone for Australian's first national clinical guidelines for perimenopause and menopause - Australian Government Department of Health, Disability and Ageing

Milestone for Australian's first national clinical guidelines for perimenopause and menopause Australian Government Department of Health, Disability and Ageing

Published: Oct. 19, 2025, 11:41 p.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti - PharmiWeb.com

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti PharmiWeb.com

Published: Oct. 18, 2025, 1:03 p.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Lelezard

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Lelezard

Published: Oct. 18, 2025, 12:47 p.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - The AI Journal

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer The AI Journal

Published: Oct. 18, 2025, 10:20 a.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - GlobeNewswire

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer GlobeNewswire

Published: Oct. 18, 2025, 10 a.m.
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Yahoo Finance

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Yahoo Finance

Published: Oct. 18, 2025, 10 a.m.
For years, countless women have been living with excruciating pain, bloating and fatigue - symptoms too often dismissed as 'just part of being a woman' - facebook.com

For years, countless women have been living with excruciating pain, bloating and fatigue - symptoms too often dismissed as 'just part of being a woman' facebook.com

Published: Oct. 17, 2025, 12:51 p.m.
For years, countless women have been living with excruciating pain, bloating and fatigue - symptoms too often dismissed as 'just part of being a woman' - Facebook

For years, countless women have been living with excruciating pain, bloating and fatigue - symptoms too often dismissed as 'just part of being a woman' Facebook

Published: Oct. 17, 2025, 12:51 p.m.
Dylan Sprouse wins hearts for raising endometriosis awareness for Barbara Palvin - The Express Tribune

Dylan Sprouse wins hearts for raising endometriosis awareness for Barbara Palvin The Express Tribune

Published: Oct. 16, 2025, 1:26 p.m.
Proteomics bolsters endometriosis product with dual Aussie partnership - The Sydney Morning Herald

Proteomics bolsters endometriosis product with dual Aussie partnership The Sydney Morning Herald

Published: Oct. 15, 2025, 8:03 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!